PACIRA PHARMACEUTICALS INC's ticker is and the CUSIP is 695127AB6.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,452,000 | +153.7% | 3,160,000 | +172.4% | 0.38% | +104.3% |
| Q3 2016 | $1,755,000 | -45.4% | 1,160,000 | -46.3% | 0.19% | -54.1% |
| Q2 2016 | $3,212,000 | -69.1% | 2,160,000 | -54.0% | 0.41% | -75.6% |
| Q1 2016 | $10,411,000 | -41.5% | 4,700,000 | -17.5% | 1.68% | -50.4% |
| Q4 2015 | $17,809,000 | +747.6% | 5,700,000 | +375.0% | 3.39% | +520.1% |
| Q3 2015 | $2,101,000 | – | 1,200,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 6,600,000 | $25,842,000 | 3.17% |
| WHITEBOX ADVISORS LLC | 13,657,000 | $53,331,000 | 2.07% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,393,000 | $83,860,000 | 1.75% |
| MACKAY SHIELDS LLC | 5,466,000 | $21,372,000 | 1.11% |
| SSI INVESTMENT MANAGEMENT LLC | 767,000 | $3,000,000 | 0.29% |
| Citadel Advisors | 29,628,000 | $115,835,000 | 0.12% |
| Visium Asset Management, LP | 1,500,000 | $5,884,000 | 0.09% |
| LAZARD ASSET MANAGEMENT LLC | 4,884,000 | $19,072,000 | 0.04% |
| FRANKLIN RESOURCES INC | 5,880,000 | $22,991,000 | 0.01% |
| Invesco Ltd. | 1,500,000 | $5,858,000 | 0.00% |